(Q34063642)

English

Telomerase inhibitors: targeting the vulnerable end of cancer?

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

title

Telomerase inhibitors: targeting the vulnerable end of cancer? (English)

1 reference

stated in

Europe PubMed Central

30 July 2017

Kelland LR

1

1 reference

stated in

Europe PubMed Central

PubMed ID

11036953

retrieved

30 July 2017

language of work or name

1 reference

1 August 2000

1 reference

stated in

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

11

1 reference

stated in

Europe PubMed Central

30 July 2017

7

1 reference

stated in

Europe PubMed Central

30 July 2017

503-513

1 reference

stated in

Europe PubMed Central

30 July 2017

Extension of life-span by introduction of telomerase into normal human cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.279.5349.349

A telomerase component is defective in the human disease dyskeratosis congenita

1 reference

stated in

COCI

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1038/990141

retrieved

15 July 2023

Identifiers

DOI

10.1097/00001813-200008000-00001

1 reference

stated in

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

PubMed ID

11036953

retrieved

30 July 2017

(Q34063642)

Telomerase inhibitors: targeting the vulnerable end of cancer?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)